Proof of Concept (Design Validation) in Patient With Hard to Heal Wounds Such as Pressure Ulcer, Diabetic Foot Ulcer and Leg Ulcer, Leia

This study has been terminated.
Information provided by (Responsible Party):
Molnlycke Health Care AB Identifier:
First received: October 9, 2013
Last updated: December 22, 2015
Last verified: December 2015
The purpose of this reseach study is to determine Mölnlycke Health Care´s Leia dressing performance properties is fulfilled and that the dressing is safe when used on wound types such as pressure ulcer, leg ulcer, and diabetic foot ulcer.

Condition Intervention Phase
Leg Ulcer
Diabetic Foot Ulcer
Pressure Ulcer
Device: Leia
Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: An Open Randomised, Prospective, Crossover, Proof of Concept (Design Validation) Clinical Investigation to Caompare the Performance and Safety of Wound Dressing(Leia) Compared to and Hydroactive Surgical Dressing on Low to Highly Exuding Wounds

Resource links provided by NLM:

Further study details as provided by Molnlycke Health Care AB:

Primary Outcome Measures:
  • Absorption of Wound Exudates. [ Time Frame: 2-3 weeks ] [ Designated as safety issue: No ]
    Absorption capacity measured subjectively: NA/POOR/GOOD/VERY GOOD/EXCELLENT

Enrollment: 6
Study Start Date: September 2013
Study Completion Date: March 2014
Primary Completion Date: February 2014 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Device, dressing
Intervention: Device, Leia dressing
Device: Leia
Other Names:
  • Leia consist of conducting and absorbing part.
  • Device: Hydroactive surgical dressing
  • It is a synergetic combination of a hydroactive surgical dressing
Active Comparator: Dressing , device
Intervention: Device: Hydroactive surgical dressing
Device: Leia
Other Names:
  • Leia consist of conducting and absorbing part.
  • Device: Hydroactive surgical dressing
  • It is a synergetic combination of a hydroactive surgical dressing


Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Low to highly exuding chronic wound(wound history > 2 months) such as Leg Ulcer, Pressure Ulcer Category III to IV or Diabetic Foot Ulcer
  • Male of female, 18 years and above
  • Signed Informed Consent Form

Exclusion Criteria:

  • Pregnancy or lactation
  • Wound size not suitable for the wound dressing size
  • Known allergy/hypersensitivity to any of the components in the dressing
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01966380

Sahlgrenska clinical trial center
Göteborg, Sweden, 41346
Sponsors and Collaborators
Molnlycke Health Care AB
  More Information

Responsible Party: Molnlycke Health Care AB Identifier: NCT01966380     History of Changes
Other Study ID Numbers: Leia 
Study First Received: October 9, 2013
Results First Received: January 14, 2015
Last Updated: December 22, 2015
Health Authority: Sweden: Regional Ethical Review Board

Additional relevant MeSH terms:
Diabetic Foot
Foot Ulcer
Leg Ulcer
Pressure Ulcer
Cardiovascular Diseases
Diabetes Complications
Diabetes Mellitus
Diabetic Angiopathies
Diabetic Neuropathies
Endocrine System Diseases
Foot Diseases
Pathologic Processes
Skin Diseases
Skin Ulcer
Vascular Diseases processed this record on May 30, 2016